Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Safety and Efficacy Study of the PTMA Device to Reduce Mitral Valve Regurgitation in Patients With Heart Failure
- Conditions
- Mitral RegurgitationHeart Failure
- First Posted Date
- 2008-12-30
- Last Posted Date
- 2011-02-14
- Lead Sponsor
- Viacor
- Target Recruit Count
- 20
- Registration Number
- NCT00815386
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
🇨🇦Royal Victoria Hospital, McGill University Medical Center, Montreal, Quebec, Canada
🇨🇦Laval Hospital, Quebec Heart-Lung Institute, Quebec City, Quebec, Canada
Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients
- Conditions
- Heart FailureMitral Regurgitation
- First Posted Date
- 2008-11-07
- Last Posted Date
- 2011-02-14
- Lead Sponsor
- Viacor
- Target Recruit Count
- 30
- Registration Number
- NCT00787293
- Locations
- 🇧🇪
Onze Lieve Vrouw Ziekenhuis Cardiovasculair Ondrezoek Aalst, Aalst, Belgium
🇧🇪Centre Hospitalier Universitaire de Liège, Liège, Belgium
🇨🇿Institut Klinicke a Experimentalni Mediciny, Prague, Czech Republic
Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
- Conditions
- Heart FailureMitral Regurgitation
- First Posted Date
- 2007-12-12
- Last Posted Date
- 2008-11-06
- Lead Sponsor
- Viacor
- Target Recruit Count
- 4
- Registration Number
- NCT00572091
- Locations
- 🇩🇪
Rheinisch-Westfalische Technische Hochschule, Universitätsklinikum Aachen, Aachen, Germany
Montreal Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device
- Conditions
- Heart FailureMitral Regurgitation
- First Posted Date
- 2007-12-12
- Last Posted Date
- 2008-11-06
- Lead Sponsor
- Viacor
- Target Recruit Count
- 5
- Registration Number
- NCT00571610
- Locations
- 🇨🇦
Montreal Heart Institute, Montreal, Quebec, Canada
Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
- Conditions
- Heart FailureMitral Regurgitation
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2008-11-06
- Lead Sponsor
- Viacor
- Target Recruit Count
- 12
- Registration Number
- NCT00568230
- Locations
- 🇩🇪
Universitat Duisburg-Essen, Essen, Germany